Myriad Genetics Stock Symbol
Myriad genetics inc is a diagnostics & research business based in the us. Myriad genetics is registered under the ticker nasdaq:mygn.
The company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests.
Myriad genetics stock symbol. What is the 52 week high and low for myriad genetics (nasdaq: Since then, mygn stock has increased by 123.0% and is now trading at $31.28. Real time myriad genetics (mygn) stock price quote, stock graph, news & analysis.
The diagnostics segment provides testing and collaborative development of testing that is designed to assess. Illuminating the path to better health through genetic insights. As with many other companies myriad genetics, inc.
Is a molecular diagnostic company. Stock analysis for myriad genetics inc (mygn:nasdaq gs) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The investor relations website contains information about myriad genetics, inc.'s business for stockholders, potential investors, and financial analysts.
Myriad genetics provides no 2021 outlook after poor performance, fve remains the same. The company offers myrisk hereditary cancer, a dna sequencing test for hereditary cancers; Myriad genetics stock quotes can also be displayed as nasdaq:
(mygn) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest myriad genetics, inc. Mygn) myriad genetics trades on the nasdaq under the ticker symbol mygn.
Also known as myriad pharmaceuticals. Mygn | complete myriad genetics inc. View a stock's price, volume, volatility and other statistics, as well as a price chart, news, performance vs.
Discover the future of myriad genetics and how we're empowering every individual by revealing the answers inside each of us. Salt lake city, ut 84108. Find the latest myriad genetics, inc.
Founders mark skolnick, peter d. Myriad genetics, inc.'s stock symbol is mygn and currently trades under nasdaq. Myriad genetics shares (mygn) are listed on the nasdaq and all prices are listed in us dollars.
It’s current price per share is approximately $ 26.61. When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. Peers and a company profile.
Bracanalysis, a dna sequencing test to assess the risk of developing breast and ovarian cancer; Myriad genetics, inc., a molecular diagnostic company, develops and markets predictive, personalized, and prognostic medicine tests in the united states and internationally. Myriad genetics personalized medicine company dedicated to being a trusted advisor.
Ipo date oct 13, 1995 Mygn), a leader in genetic testing and precision medicine, today. The company operates through two segments:
Post a Comment for "Myriad Genetics Stock Symbol"